Nutex Health Inc. (NASDAQ:NUTX) Short Interest Up 198.9% in July

Nutex Health Inc. (NASDAQ:NUTX) was the target of a significant growth in short interest during the month of July. As of July 15th, there was short interest totalling 108,500 shares, a growth of 198.9% from the June 30th total of 36,300 shares. Based on an average trading volume of 30,100 shares, the days-to-cover ratio is presently 3.6 days. Currently, 3.9% of the company’s stock are sold short.

Nutex Health Stock Down 0.1 %

Nutex Health stock traded down $0.01 during mid-day trading on Thursday, hitting $7.45. 31,195 shares of the company’s stock were exchanged, compared to its average volume of 26,791. The stock has a market cap of $37.03 million, a P/E ratio of -0.70 and a beta of -0.07. The stock has a 50 day moving average of $6.17 and a two-hundred day moving average of $12.16. Nutex Health has a 1-year low of $4.16 and a 1-year high of $63.00. The company has a current ratio of 1.68, a quick ratio of 1.63 and a debt-to-equity ratio of 2.99.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.10) earnings per share (EPS) for the quarter. The business had revenue of $67.45 million during the quarter. Nutex Health had a negative net margin of 15.85% and a negative return on equity of 44.06%.

Insider Transactions at Nutex Health

In related news, CEO Thomas T. Vo purchased 4,839 shares of the company’s stock in a transaction dated Tuesday, May 28th. The shares were acquired at an average cost of $7.00 per share, with a total value of $33,873.00. Following the completion of the purchase, the chief executive officer now owns 1,805,390 shares of the company’s stock, valued at approximately $12,637,730. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last ninety days, insiders have purchased 8,870 shares of company stock valued at $58,598. 38.52% of the stock is owned by insiders.

Institutional Investors Weigh In On Nutex Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. Beaird Harris Wealth Management LLC grew its position in shares of Nutex Health by 210.0% in the fourth quarter. Beaird Harris Wealth Management LLC now owns 930,282 shares of the company’s stock valued at $167,000 after purchasing an additional 630,168 shares during the last quarter. GDS Wealth Management lifted its stake in shares of Nutex Health by 98.2% in the fourth quarter. GDS Wealth Management now owns 1,110,051 shares of the company’s stock valued at $200,000 after buying an additional 550,026 shares during the period. Truist Financial Corp lifted its stake in shares of Nutex Health by 86.0% in the fourth quarter. Truist Financial Corp now owns 4,367,317 shares of the company’s stock valued at $786,000 after buying an additional 2,018,966 shares during the period. Finally, One Plus One Wealth Management LLC lifted its stake in shares of Nutex Health by 2,017.5% in the first quarter. One Plus One Wealth Management LLC now owns 5,293,720 shares of the company’s stock valued at $508,000 after buying an additional 5,043,720 shares during the period. 5.32% of the stock is owned by institutional investors and hedge funds.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.